High-throughput screen with the l,d-transpeptidase LdtMt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors. (2023)
Attributed to:
CHNUK: Integrated platforms from science to policy in response to antibacterial resistance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d2sc06858c
PubMed Identifier: 37416715
Publication URI: http://europepmc.org/abstract/MED/37416715
Type: Journal Article/Review
Volume: 14
Parent Publication: Chemical science
Issue: 26
ISSN: 2041-6520